US Bancorp’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.8K Buy
2,560
+11
+0.4% +$243 ﹤0.01% 2717
2025
Q4
$61.6K Buy
2,549
+62
+2% +$1.62K ﹤0.01% 2604
2025
Q3
$63.4K Sell
2,487
-147
-6% -$3.49K ﹤0.01% 2556
2025
Q2
$56.7K Buy
2,634
+479
+22% +$10.8K ﹤0.01% 2718
2025
Q1
$49.2K Buy
2,155
+1,528
+244% +$40.2K ﹤0.01% 2758
2024
Q4
$16.3K Buy
627
+239
+62% +$5.95K ﹤0.01% 3240
2024
Q3
$9.71K Buy
388
+89
+30% +$2.1K ﹤0.01% 3373
2024
Q2
$6.41K Buy
299
+190
+174% +$3.69K ﹤0.01% 3441
2024
Q1
$2.02K Sell
109
-2,411
-96% -$42.2K ﹤0.01% 3722
2023
Q4
$41K Buy
2,520
+1,989
+375% +$25.4K ﹤0.01% 2768
2023
Q3
$7.33K Sell
531
-102
-16% -$1.61K ﹤0.01% 3287
2023
Q2
$14K Sell
633
-4,324
-87% -$91.1K ﹤0.01% 3135
2023
Q1
$108K Sell
4,957
-476
-9% -$10.7K ﹤0.01% 2147
2022
Q4
$98.9K Sell
5,433
-19,386
-78% -$400K ﹤0.01% 2200
2022
Q3
$564K Sell
24,819
-16,842
-40% -$360K ﹤0.01% 1331
2022
Q2
$575K Sell
41,661
-3,076
-7% -$45.1K ﹤0.01% 1365
2022
Q1
$1.02M Sell
44,737
-600
-1% -$15.8K ﹤0.01% 1178
2021
Q4
$1.69M Buy
45,337
+1,095
+2% +$47K ﹤0.01% 974
2021
Q3
$1.87M Buy
44,242
+40,666
+1,137% +$1.96M ﹤0.01% 900
2021
Q2
$159K Buy
3,576
+739
+26% +$26K ﹤0.01% 2067
2021
Q1
$102K Buy
2,837
+2,792
+6,204% +$110K ﹤0.01% 2261
2020
Q4
$2K Hold
45
﹤0.01% 3553
2020
Q3
$1K Buy
+45
New +$972 ﹤0.01% 3563

Other funds holding BLFS